Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy
- Registration Number
- NCT02247648
- Lead Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Brief Summary
The investigators hypothesize that the use of tramadol will reduce pain and analgesic consumption after arthroscopic shoulder surgery.
- Detailed Description
The purpose of the study was to evaluate the efficacy of tramadol long acting for post operative pain in patients who had an arthroscopic shoulder surgery in ambulatory setting in comparison with a placebo. The intensity of pain was evaluated on a visual analog scale as the quantity of hydromorphone taken by patients, and the side effects during the first 72 hours.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- aged more than 18 year old
- arthroscopic shoulder surgery on interscalen block
- able to understand the protocol
- inform consent signed
Exclusion Criteria
- chronic pain or chronic used of narcotics
- Use of IMAO
- Use of ISRS
- Pulmonary chronic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control Placebo control: placebo group treatment tramadol treatment: tramadol group
- Primary Outcome Measures
Name Time Method quantity of hydromorphone consumed 3 days determination of the quantity of hydromorphone consumed at different laps
- Secondary Outcome Measures
Name Time Method evaluation of pain (The intensity of pain was evaluated on a visual analog scale) 3 days evaluation of the pain at different laps
Trial Locations
- Locations (1)
Institut de chirurgie spécialisée de Montréal
🇨🇦Montréal, Quebec, Canada